Literature DB >> 8233734

Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study.

T Q Tan1, E O Mason, S L Kaplan.   

Abstract

OBJECTIVE: To determine whether there are any risk factors that differentiate children with systemic infections due to Streptococcus pneumoniae relatively or fully resistant (minimum inhibitory concentration > 0.1 microgram/mL) to penicillin from those children with infections due to S pneumoniae susceptible to penicillin.
DESIGN: Retrospective case-control study.
SETTING: A large children's hospital. PARTICIPANTS: Forty-three children with systemic penicillin-resistant S pneumoniae infections identified at Texas Children's Hospital over the 51-month period from January 1989 through March 1993. Each case had one or two controls matched only for age and date of S. pneumoniae infection. Sixty-six controls were selected from a group of 341 children with susceptible isolates. OUTCOME MEASURES: Variables compared included gender, race, diagnosis, underlying conditions, past hospitalization, geographic area of residence, antibiotic use in past month, amoxicillin-clavulanic acid use in past month, and outcome.
RESULTS: Thirty-seven patients (86%) had relatively resistant isolates (minimum inhibitory concentration range 0.125 to 1.0 microgram/mL) and six patients (15%) had fully resistant isolates (minimum inhibitory concentration range 2.0 to 8.0 micrograms/mL). Thirty-three percent of the cases vs 36% of the controls had underlying conditions. Seventy-one percent of the cases vs 39% of the controls had received antibiotics in the previous month. Compared with their matched controls, the patients with penicillin-resistant systemic pneumococcal infections were more likely (P = .02) to have received a course of antibiotics within the month prior to their infection.
CONCLUSION: The only identified associated risk factor in children who developed a systemic penicillin-resistant pneumococcal infection appears to have been the use of antibiotics within the month prior to their infection.

Entities:  

Mesh:

Year:  1993        PMID: 8233734

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Managing patients with an absent or dysfunctional spleen. Guidelines do not discuss resistance to antibiotics among pneumococci.

Authors:  H P Lambert
Journal:  BMJ       Date:  1996-05-25

Review 2.  Strategies for promoting judicious use of antibiotics by doctors and patients.

Authors:  E A Belongia; B Schwartz
Journal:  BMJ       Date:  1998-09-05

3.  Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study.

Authors:  Henry D Kalter; Robert H Gilman; Lawrence H Moulton; Anna R Cullotta; Lilia Cabrera; Billie Velapatiño
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.

Authors:  U D Allen; N MacDonald; L Fuite; F Chan; D Stephens
Journal:  CMAJ       Date:  1999-05-18       Impact factor: 8.262

5.  Serious infections due to penicillin-resistant Streptococcus peneumoniae in two children with nephrotic syndrome.

Authors:  M Ilyas; S Roy; S Abbasi; R J Leggiadro; B K English; R J Wyatt
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

6.  Penicillin resistant pneumococcal infection--a serious concern for India.

Authors:  M Hiranandani; I Kaur
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

7.  Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats.

Authors:  C C Butler; S Rollnick; R Pill; F Maggs-Rapport; N Stott
Journal:  BMJ       Date:  1998-09-05

8.  Penicillin resistance in laboratory isolates of Streptococcus pneumoniae, in Western Australia, 1990-1994.

Authors:  V A McLaughlin; T V Riley; C L Roberts
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

9.  Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

Authors:  R F Jacobs; S L Kaplan; G E Schutze; A S Dajani; R J Leggiadro; C S Rim; S K Puri
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.